Skip to content
Open main menu
Projects
Back to Menu
All Projects
Commercial
Back to Projects
Commercial
Navigation
M17-380 (Start-Up)
LTS17367 (River-AD)
B7981027 (Alopecia Trial)
M19-973 (Optimmize-2)
INCB – 18424-3009 (Ruxolitinib – Vitiligo)
Non-Commercial
Back to Projects
Non-Commercial
Navigation
A-STAR
Back to Menu
Chart-AD
ASTAR-BIO
A-STAR Project team
Committees and collaborators
Information and resources for participating sites
Information for Participants
News and Publications
Participating centres
FAQ’s
AD Pheno-Biome
Back to Menu
AD Pheno-Biome
AD Pheno-Biome project team
Biomap (Completed)
DREAM TO TREAT AD
EAT Study (Completed)
Eczema Therapies (Completed)
The Global Atopic Dermatitis Atlas (GADA)
Kids in Control
Back to Menu
Mind and Skin Consortium
Back to Menu
Mind and Skin Consortium
Mind and Skin Consortium Project team
SLEEP Study
SECURE-AD Covid-19 atopic dermatitis study (Completed)
TRANS-FOODS
TREAT (Completed)
LEAD-NLP
CUTIE
CARE
FACE
Patient stories
Publicity
Publications
Core team
Close menu
Projects
Back to Menu
All Projects
Commercial
Back to Projects
Commercial
Navigation
M17-380 (Start-Up)
LTS17367 (River-AD)
B7981027 (Alopecia Trial)
M19-973 (Optimmize-2)
INCB – 18424-3009 (Ruxolitinib – Vitiligo)
Non-Commercial
Back to Projects
Non-Commercial
Navigation
A-STAR
Back to Menu
Chart-AD
ASTAR-BIO
A-STAR Project team
Committees and collaborators
Information and resources for participating sites
Information for Participants
News and Publications
Participating centres
FAQ’s
AD Pheno-Biome
Back to Menu
AD Pheno-Biome
AD Pheno-Biome project team
Biomap (Completed)
DREAM TO TREAT AD
EAT Study (Completed)
Eczema Therapies (Completed)
The Global Atopic Dermatitis Atlas (GADA)
Kids in Control
Back to Menu
Mind and Skin Consortium
Back to Menu
Mind and Skin Consortium
Mind and Skin Consortium Project team
SLEEP Study
SECURE-AD Covid-19 atopic dermatitis study (Completed)
TRANS-FOODS
TREAT (Completed)
LEAD-NLP
CUTIE
CARE
FACE
Patient stories
Publicity
Publications
Core team
back to top
Play video
Chart-AD First Recruit
